Imperial College London

Professor Sir Roy Anderson FRS, FMedSci

Faculty of MedicineSchool of Public Health

Professor in Infectious Disease Epidemiology



+44 (0)20 7594 3399roy.anderson




Mrs Clare Mylchreest +44 (0)20 7594 9162




LG35Norfolk PlaceSt Mary's Campus






BibTex format

author = {Turner, HC and Toor, J and Hollingsworth, TD and Anderson, RM},
doi = {cid/cix1001},
journal = {Clin Infect Dis},
title = {Economic evaluations of mass drug administration: The importance of economies of scale and scope.},
url = {},
year = {2017}

RIS format (EndNote, RefMan)

AB - It is recognised that changing the current approaches for the control of the neglected tropical diseases will be needed to reach the World Health Organization's (WHO) 2020 goals. Consequently, it is important that economic evaluations of the alternative approaches are conducted. A vital component of such evaluations is the issue of how the intervention's costs should be incorporated. We discuss this issue - focusing on mass drug administration. We argue that the common approach of assuming an intervention's cost per treatment is constant, regardless of the number of individuals treated, is a misleading way to consider the delivery costs of mass drug administration due to the occurrence of economies/diseconomies of scale and scope. Greater care and consideration are required when the costs are incorporated into such analyses. Without this, these economic evaluations could potentially lead to incorrect policy recommendations.
AU - Turner,HC
AU - Toor,J
AU - Hollingsworth,TD
AU - Anderson,RM
DO - cid/cix1001
PY - 2017///
TI - Economic evaluations of mass drug administration: The importance of economies of scale and scope.
T2 - Clin Infect Dis
UR -
UR -
ER -